Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
2.020
+0.070 (3.59%)
Jul 10, 2025, 4:00 PM - Market closed

Outlook Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Jul '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
871265827638092
Upgrade
Market Cap Growth
-84.56%119.64%-79.15%-27.49%315.51%117.68%
Upgrade
Enterprise Value
1121275926037273
Upgrade
Last Close Price
2.025.344.4224.4043.4014.40
Upgrade
PB Ratio
--1.73-3.9831.5882.5832.40
Upgrade
P/TBV Ratio
---31.5882.5832.40
Upgrade
Debt / Equity Ratio
-1.03-0.41-2.461.252.581.71
Upgrade
Quick Ratio
0.300.350.500.882.140.84
Upgrade
Current Ratio
0.720.640.661.403.191.13
Upgrade
Return on Equity (ROE)
----989.99%-1430.33%-
Upgrade
Return on Assets (ROA)
-122.33%-146.63%-109.17%-153.56%-151.98%-123.12%
Upgrade
Return on Capital (ROIC)
---162.72%-217.76%-267.59%-383.73%
Upgrade
Earnings Yield
24.40%-59.66%-102.55%-23.94%-13.97%-38.48%
Upgrade
FCF Yield
-73.99%-54.46%-74.72%-20.54%-14.26%-34.72%
Upgrade
Buyback Yield / Dilution
-91.92%-48.29%-17.96%-38.91%-110.43%-298.84%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q